UK: Guide To Draft Protocols For Low Value EL, PL And RTA Claims

Last Updated: 7 November 2012
Article by Simon Denyer and Nigel Teasdale

Back in January 2012, the Government announced that the current RTA portal scheme for low value claims up to £10,000 would be extended to EL, PL and motor claims with a value up to £25,000.  The MoJ then issued a call for evidence on how the Pre-Action Protocol, the portal and costs regime should be modified to accommodate the extension. Only now has the detail started to emerge with the Civil Procedure Rule Committee releasing the draft Pre-Action Protocols together with a short consultation closing on 23 November which seeks views on whether those Protocols are workable and whether they can be improved in any way.

Some aspects of the draft Protocols, which are the result of Government policy decisions, are not open for adjustment. They are:

(i)     the schedule of costs to be used in conjunction with the Protocols (Professor Fenn is currently updating his work on this).

(ii)    the exclusion of certain claims from the scope of the Pre-Action Protocols; and

(iii)   the response periods within Stage 1 of the Protocols.

This update highlights the key provisions of the amended RTA Protocol and the new EL/PL Protocol and looks at the challenges ahead before implementation in April 2013.

RTA Protocol

Increase of Protocol upper limit to £25,000 – this is the key change to the existing Protocol. The upper limit of £25,000 will apply to accidents occurring on or after 6 April 2013 and it will remain at £10,000 for accidents before that date.

Costs sanctions - there is a new warning in the Preamble that the court is able to impose costs sanctions when the Protocol is not followed.

Mandatory use of the portal and email - use of the portal is now mandatory where the Protocol requires information to be sent to a party. There is also a new requirement that all written communications not required by the Protocol are to be sent by email, for example in relation to a claim for hire charges being dealt with outside the Protocol.

Stage 1 - fixed costs – end of the £400 club - the time for payment of Stage 1 fixed costs has changed. Instead of having to pay within 10 days of the liability response, payment will now be within 10 days after receiving the Stage 2 Settlement Pack.

Stage 2 - medical records and photographs – the claimant must now disclose with the medical report any medical records which the medical expert considers relevant. However, it is expected that in claims under £10,000 the medical expert will not need to see any medical records. In addition, relevant photographs of the claimant's injuries should also be disclosed.

Stage 2 - subsequent medical reports - the wording has changed slightly to emphasise that any subsequent medical report must be "justified" and there is an additional justification for a further report where "the claimant has not recovered as expected in the original prognosis".

Stage 2 - non-medical expert reports – there is now provision for a non-medical expert report where it is reasonably required to value the claim.

Stage 2- witness statements – a new provision states that witness statements will not be required in most cases but statements may be provided where reasonably required to value the claim.

EL / PL Protocol

Types of claims included - an EL or PL accident occurring on or after 1 April 2013 or in an EL disease claim where no letter of claim has been sent to the defendant before 1 April 2013.

Types of claims excluded - the Protocol does not apply to:

  • PL disease claims;
  • PL claims where the defendant is an individual (not including a defendant who is sued in the name of their business or in their capacity as an office holder);
  • claims where the defendant is insolvent and there is no identifiable insurer;
  • a disease claim where there is more than one defendant;
  • claims for damages in relation to harm, abuse or neglect of or by children, young people and vulnerable adults;
  • clinical negligence claim;
  • mesothelioma claims.

Stage 1 – Claim Notification Form (CNF) - the claimant must send the CNF to the defendant's insurer and Defendant Only CNF to the defendant.If the insurer is not known or there is no insurance, the CNF must be sent to the defendant. However, the claimant must make a reasonable attempt to identify the insurer. In an EL claim, the claimant must carry out a search through the Employers' Liability Tracing Office. In a disease claim, the CNF should be sent to the last insurer on risk for the material period of employment. If the CNF or Defendant Only CNF cannot be sent to the defendant via the portal, it must be sent via first class post.

Response – acknowledgment - the defendant must send an electronic acknowledgment the day after receipt of the CNF. If the claimant has sent the CNF to the defendant direct, the defendant must send an electronic acknowledgment to the claimant the day after its receipt and send the CNF to the insurer at the same time. The insurer must then send an electronic acknowledgment to the claimant the day after its receipt from the defendant.

Response – liability decision - the response period in an EL claim is 30 days from deemed service of the CNF, and in a PL claim, 40 days. The number of days is a reference to business days and so practically speaking, the periods are 6 and 8 weeks respectively.

Contributory negligence - where there is an admission of liability but the defendant alleges any degree of contributory negligence the claim will drop out of the Protocol.

Experts' reports and medical records – the provisions for the obtaining of medical and non-medical evidence are the same as under the RTA Protocol, save that there is no suggestion that in claims under £10,000 the medical expert will not need to see any medical records.

Interim payments – where a claim is valued at more than £10,000 the claimant may request more than one interim payment. This provision is not available in the RTA Protocol.

Success fees – there is provision for payment of success fees in disease claims where a CFA was entered into before 1 April 2013 or in the case of a CCFA advocacy or litigation services were provided under the agreement in connection with the claim before 1 April 2013. Unlike EL and PL accident claims where there can be no claim for a success fee as the reforms in relation to recoverable success fees come into force on the same day as these changes, as in disease claims these reforms only impact by reference to the date of the letter of claim. There will therefore be some EL disease claims where though the letter of claim is sent after 1 April 2013, the CFA/CCFA will have incepted in relation to the claim prior to that date, so as to entitle that claimant to a success fee recoverable from the defendant.

Lost earnings – in an EL claim, the defendant must provide earnings details to verify any claim for loss of earnings within 20 days of the date of the admission.



On the motor side, the £400 club has long been a concern for insurers who will welcome this amendment. Not only should it allay concern over fraudulent claims brought solely to obtain Stage 1 costs but it should also encourage claimants to move more quickly to Stage 2.

We are surprised however, how few changes are proposed to the RTA Protocol notwithstanding the issues which have emerged since the Protocol started. Even with claims valued up to £10,000 there have been concerns about the lack of provision for defendants to either question experts or obtain their own medical evidence. This has been compounded by the reversion to a position where there is no obligation to nominate proposed experts.

The amended Protocol does now provide for the review and disclosure of medical records but the other issues have not been addressed. It may be that further progress can be made in this regard when we eventually see the whiplash consultation which is expected to consider the introduction of independent medical panels.


On the EL/ PL side, there has been much anticipation over the response period for a liability decision. At six and eight weeks, this represents roughly half of the three month period available to insurers under the current Personal Injury Pre-Action Protocol. This is a key period in which to decide whether there is a defence on primary liability, worthwhile allegations of contributory negligence, or potential fraud. Quicker investigation processes will be required and desk top enquiries may become the normal approach unless an early decision is made to allow the case to drop out of the Protocol allowing more time to investigate the aspect that has caused the claim to come out.

An additional factor to be considered when the Protocol commences, is that at the same time, legislation (an amendment to s.47 Health & Safety at Work Act 1974 via the Enterprise and Regulatory Reform Bill) is also due to come into force. This proposal is designed to ensure that defendants will only be liable for civil damages in EL and PL claims which are governed by the current regulatory health and safety regime if they can be shown to have acted negligently, and while this will lead to certain additional claims becoming defensible, this may result in further investigations being required to obtain evidence showing implementation of a safe system of work. If it is believed that any case of this type could now be defended on this basis, then that would be good reason for that claim to leave the portal process.


Experience suggests that few letters of claim in disease matters currently contain sufficient information for an adequate investigation of all coverage and liability issues within the existing standard protocol period. It seems likely there will be many claims immediately exiting this new process under a para 6.14(4) notice (inadequate mandatory information in the CNF). Issues of breach of duty, limitation and causation are all interwoven in disease claims and do not sit easily within the envisaged process. Insurers are well advised to steer away from "blanket admissions" in disease claims where there is always a need to consider precisely what is being admitted and how that might impact on causation. How can limitation be properly considered without access to medical records and a medical report outlining the development of the condition? Many disease claims will be excluded as they involve more than one potential Defendant. There may be reasonable grounds for arguing the same should in practice apply to all long tail disease claims by insurers allowing them to exit from these new proposed processes.

Unprecedented change

This consultation emphasises that the Government remains committed to these reforms being in place for April which is now under five months away. The portal processes may take some time after April to be fully implemented in terms of case numbers both with the larger motor claims and with EL and PL, as the participants to the new processes complete their own thought and process development.

Ultimately, the picture is still not complete without knowing what is being proposed in terms of portal costs, pre-litigation fixed costs and the rumoured fast track fixed costs. Insurers and those policyholders who will be directly involved in the Protocol process need this outstanding data to be able to decide on a strategic and case specific approach in response. They will want to know their costs liability for allowing claims to stay within the Protocol, and to what extent that exposure will be greater if they are allowed to drop out of the Protocol.

The time for claimants and insurers to finalise strategic consideration is going to be very short when all the detail becomes apparent. DWF already has significant experience in the operation of the current RTA Protocol and is available to provide support and training both on a practical and strategic level. We will update further as additional information becomes available during this time of unprecedented change.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.